DNK 333: a dual neurokinin NK1/NK2 receptor antagonist; structure in first source [MeSH]
| Synonym |
|---|
| dnk333 |
| CHEMBL105060 , |
| 3-[4-(3,4-dichlorophenyl)-3-[3,5-di(trifluoromethyl)phenyl(methyl)carboxamido]-(e,3r)-1-butenylcarboxamido]-2-oxo-(3r)-azepane |
| n-[(r,r)-(e)-(3,4-dichlorobenzyl)-3-(2-oxoazepan-3-yl)carbamoyl]allyl-n-methyl-3,5-bis(trifluoromethyl)benzamide |
| bdbm50106892 |
| n-[(e)-(r)-1-(3,4-dichloro-benzyl)-3-((r)-2-oxo-azepan-3-ylcarbamoyl)-allyl]-n-methyl-3,5-bis-trifluoromethyl-benzamide |
| n-((r,r)-(e)-1-(3,4-dichlorobenzyl)-3-(2-oxoazepan-3-yl)carbamoyl)allyl-n-methyl-3,5-bis(trifluoromethyl)benzamide |
| g9bl4978mz , |
| dnk 333 |
| 398507-81-8 |
| unii-g9bl4978mz |
| benzamide, n-((1r,2e)-1-((3,4-dichlorophenyl)methyl)-4-(((3r)-hexahydro-2-oxo-1h-azepin-3-yl)amino)-4-oxo-2-butenyl)-n-methyl-3,5-bis(trifluoromethyl)- |
| (+)-dnk-333 |
| dnk-333 |
| SCHEMBL868320 |
| SCHEMBL16353812 |
| n-[(e,2r)-1-(3,4-dichlorophenyl)-5-oxo-5-[[(3r)-2-oxoazepan-3-yl]amino]pent-3-en-2-yl]-n-methyl-3,5-bis(trifluoromethyl)benzamide |
| Q27278966 |
| n-((r,e)-1-(3,4-dichlorophenyl)-5-oxo-5-(((r)-2-oxoazepan-3-yl)amino)pent-3-en-2-yl)-n-methyl-3,5-bis(trifluoromethyl)benzamide |
| Assay ID | Title | Year | Journal | Article |
|---|
| AID208600 | In vitro binding affinity towards Human Tachykinin receptor 1 | 2003 | Journal of medicinal chemistry, Jul-31, Volume: 46, Issue:16
ISSN: 0022-2623 | Stereoselective preparation of N-[(R,R)-(E)-1-(3,4-dichlorobenzyl)-3- (2-oxoazepan-3-yl)carbamoyl]allyl-N-methyl-3,5-bis(trifluoromethyl)benzamide, a potent and orally active dual neurokinin NK(1)/NK(2) receptor antagonist. |
| AID25451 | Area Under the concentration-time curve from zero time to 24 hr in guinea pig when given at a dose of 10 mg/kg perorally (Microemulsion) | 2003 | Journal of medicinal chemistry, Jul-31, Volume: 46, Issue:16
ISSN: 0022-2623 | Stereoselective preparation of N-[(R,R)-(E)-1-(3,4-dichlorobenzyl)-3- (2-oxoazepan-3-yl)carbamoyl]allyl-N-methyl-3,5-bis(trifluoromethyl)benzamide, a potent and orally active dual neurokinin NK(1)/NK(2) receptor antagonist. |
| AID28338 | Plasma concentration in Blood of guinea pig when given at a dose of 10 mg/kg perorally | 2003 | Journal of medicinal chemistry, Jul-31, Volume: 46, Issue:16
ISSN: 0022-2623 | Stereoselective preparation of N-[(R,R)-(E)-1-(3,4-dichlorobenzyl)-3- (2-oxoazepan-3-yl)carbamoyl]allyl-N-methyl-3,5-bis(trifluoromethyl)benzamide, a potent and orally active dual neurokinin NK(1)/NK(2) receptor antagonist. |
| AID211893 | In vitro binding affinity towards Human Tachykinin receptor 2 | 2003 | Journal of medicinal chemistry, Jul-31, Volume: 46, Issue:16
ISSN: 0022-2623 | Stereoselective preparation of N-[(R,R)-(E)-1-(3,4-dichlorobenzyl)-3- (2-oxoazepan-3-yl)carbamoyl]allyl-N-methyl-3,5-bis(trifluoromethyl)benzamide, a potent and orally active dual neurokinin NK(1)/NK(2) receptor antagonist. |
| AID26486 | Bioavailability in guinea pig (dose 10 mg/kg p.o.) | 2003 | Journal of medicinal chemistry, Jul-31, Volume: 46, Issue:16
ISSN: 0022-2623 | Stereoselective preparation of N-[(R,R)-(E)-1-(3,4-dichlorobenzyl)-3- (2-oxoazepan-3-yl)carbamoyl]allyl-N-methyl-3,5-bis(trifluoromethyl)benzamide, a potent and orally active dual neurokinin NK(1)/NK(2) receptor antagonist. |
| AID77105 | In vivo Effective peroral dose which inhibits Beta-ala8-Neurokinin A induced bronchoconstriction (dynamic compliance) in squirrel monkey | 2003 | Journal of medicinal chemistry, Jul-31, Volume: 46, Issue:16
ISSN: 0022-2623 | Stereoselective preparation of N-[(R,R)-(E)-1-(3,4-dichlorobenzyl)-3- (2-oxoazepan-3-yl)carbamoyl]allyl-N-methyl-3,5-bis(trifluoromethyl)benzamide, a potent and orally active dual neurokinin NK(1)/NK(2) receptor antagonist. |
| AID290025 | Antagonist activity at NK1 receptor in guinea pig trachea as inhibition of ASM-SP-induced bronchoconstriction | 2007 | Bioorganic & medicinal chemistry letters, Feb-15, Volume: 17, Issue:4
ISSN: 0960-894X | Design and synthesis of 3,5-disubstituted benzamide analogues of DNK333 as dual NK1/NK2 receptor probes. |
| AID211523 | In vitro relative antagonist potency towards guinea pig Tachykinin receptor 2 | 2003 | Journal of medicinal chemistry, Jul-31, Volume: 46, Issue:16
ISSN: 0022-2623 | Stereoselective preparation of N-[(R,R)-(E)-1-(3,4-dichlorobenzyl)-3- (2-oxoazepan-3-yl)carbamoyl]allyl-N-methyl-3,5-bis(trifluoromethyl)benzamide, a potent and orally active dual neurokinin NK(1)/NK(2) receptor antagonist. |
| AID77104 | In vivo Effective peroral dose which inhibits Beta-ala8-Neurokinin A induced bronchoconstriction (airways resistance) in squirrel monkey | 2003 | Journal of medicinal chemistry, Jul-31, Volume: 46, Issue:16
ISSN: 0022-2623 | Stereoselective preparation of N-[(R,R)-(E)-1-(3,4-dichlorobenzyl)-3- (2-oxoazepan-3-yl)carbamoyl]allyl-N-methyl-3,5-bis(trifluoromethyl)benzamide, a potent and orally active dual neurokinin NK(1)/NK(2) receptor antagonist. |
| AID27212 | Half life period in guinea pig when given at a dose of 10 mg/kg perorally | 2003 | Journal of medicinal chemistry, Jul-31, Volume: 46, Issue:16
ISSN: 0022-2623 | Stereoselective preparation of N-[(R,R)-(E)-1-(3,4-dichlorobenzyl)-3- (2-oxoazepan-3-yl)carbamoyl]allyl-N-methyl-3,5-bis(trifluoromethyl)benzamide, a potent and orally active dual neurokinin NK(1)/NK(2) receptor antagonist. |
| AID208089 | In vitro binding affinity for Tachykinin receptor 1 of bovine retinal membranes using [3H]Sar9-substance P as radioligand | 2001 | Bioorganic & medicinal chemistry letters, Dec-03, Volume: 11, Issue:23
ISSN: 0960-894X | Dual neurokinin NK(1)/NK(2) antagonists: N-[(R,R)-(E)-1-arylmethyl-3-(2-oxo-azepan-3-yl)carbamoyl]allyl-N-methyl-3,5-bis(trifluoromethyl)benzamides and 3-[N'-3,5-bis(trifluoromethyl)benzoyl-N-arylmethyl-N'-methylhydrazino]-N-[(R)-2-oxo-azepan-3-yl]propion |
| AID290027 | Antagonist activity at NK2 receptor in guinea pig trachea as inhibition of [beta-Ala8]NKA(4-10)-induced bronchoconstriction | 2007 | Bioorganic & medicinal chemistry letters, Feb-15, Volume: 17, Issue:4
ISSN: 0960-894X | Design and synthesis of 3,5-disubstituted benzamide analogues of DNK333 as dual NK1/NK2 receptor probes. |
| AID25453 | Area Under the concentration-time curve from zero time to 24 hr in guinea pig when given at a dose of 3 mg/kg intravenously | 2003 | Journal of medicinal chemistry, Jul-31, Volume: 46, Issue:16
ISSN: 0022-2623 | Stereoselective preparation of N-[(R,R)-(E)-1-(3,4-dichlorobenzyl)-3- (2-oxoazepan-3-yl)carbamoyl]allyl-N-methyl-3,5-bis(trifluoromethyl)benzamide, a potent and orally active dual neurokinin NK(1)/NK(2) receptor antagonist. |
| AID211705 | In vitro binding affinity for Tachykinin receptor 2 of human-CHO cells using 125 I-NKA radioligand | 2001 | Bioorganic & medicinal chemistry letters, Dec-03, Volume: 11, Issue:23
ISSN: 0960-894X | Dual neurokinin NK(1)/NK(2) antagonists: N-[(R,R)-(E)-1-arylmethyl-3-(2-oxo-azepan-3-yl)carbamoyl]allyl-N-methyl-3,5-bis(trifluoromethyl)benzamides and 3-[N'-3,5-bis(trifluoromethyl)benzoyl-N-arylmethyl-N'-methylhydrazino]-N-[(R)-2-oxo-azepan-3-yl]propion |
| AID290026 | Antagonist activity at NK2 receptor in guinea pig trachea as inhibition of [beta-Ala8]NKA(4-10)-induced bronchoconstriction relative to control | 2007 | Bioorganic & medicinal chemistry letters, Feb-15, Volume: 17, Issue:4
ISSN: 0960-894X | Design and synthesis of 3,5-disubstituted benzamide analogues of DNK333 as dual NK1/NK2 receptor probes. |
| AID208246 | In vitro relative antagonist potency towards guinea pig Tachykinin receptor 1 | 2003 | Journal of medicinal chemistry, Jul-31, Volume: 46, Issue:16
ISSN: 0022-2623 | Stereoselective preparation of N-[(R,R)-(E)-1-(3,4-dichlorobenzyl)-3- (2-oxoazepan-3-yl)carbamoyl]allyl-N-methyl-3,5-bis(trifluoromethyl)benzamide, a potent and orally active dual neurokinin NK(1)/NK(2) receptor antagonist. |
| AID27213 | Half life period in guinea pig when given at a dose of 3 mg/kg intravenously | 2003 | Journal of medicinal chemistry, Jul-31, Volume: 46, Issue:16
ISSN: 0022-2623 | Stereoselective preparation of N-[(R,R)-(E)-1-(3,4-dichlorobenzyl)-3- (2-oxoazepan-3-yl)carbamoyl]allyl-N-methyl-3,5-bis(trifluoromethyl)benzamide, a potent and orally active dual neurokinin NK(1)/NK(2) receptor antagonist. |
| AID25452 | Area Under the concentration-time curve from zero time to 24 hr in guinea pig when given at a dose of 10 mg/kg perorally (cremophor) | 2003 | Journal of medicinal chemistry, Jul-31, Volume: 46, Issue:16
ISSN: 0022-2623 | Stereoselective preparation of N-[(R,R)-(E)-1-(3,4-dichlorobenzyl)-3- (2-oxoazepan-3-yl)carbamoyl]allyl-N-methyl-3,5-bis(trifluoromethyl)benzamide, a potent and orally active dual neurokinin NK(1)/NK(2) receptor antagonist. |
| AID290024 | Antagonist activity at NK1 receptor in guinea pig trachea as inhibition of ASM-SP-induced bronchoconstriction relative to control | 2007 | Bioorganic & medicinal chemistry letters, Feb-15, Volume: 17, Issue:4
ISSN: 0960-894X | Design and synthesis of 3,5-disubstituted benzamide analogues of DNK333 as dual NK1/NK2 receptor probes. |